Heterocyclic compounds
US-12577257-B2 · Mar 17, 2026 · US
This page is not indexed by search engines while we improve data quality.
Grether Uwe patents
Grether Uwe is listed as an inventor on 37 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Grether Uwe |
| Total patents | 37 |
| First publication | Oct 11, 2018 |
| Latest publication | Mar 17, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Azetidine-substituted pyridine and pyrazine compounds as inhibitors of cannabinoid receptor 2
US-12180196-B2 · Dec 31, 2024 · US
Novel pyridine and pyrazine compounds as inhibitors of cannabinoid receptor 2
US-2024383872-A1 · Nov 21, 2024 · US
Radiolabeled cannabinoid receptor 2 ligand
US-2024308974-A1 · Sep 19, 2024 · US
Pyridine and pyrazine compounds as inhibitors of cannabinoid receptor 2
US-12071420-B2 · Aug 27, 2024 · US
Radiolabeled cannabinoid receptor 2 ligand
US-11999710-B2 · Jun 4, 2024 · US
Heterocyclic compounds
US-11981661-B2 · May 14, 2024 · US
Heterocyclic compounds
US-11814375-B2 · Nov 14, 2023 · US
Pyridine and pyrazine derivatives as preferential cannabinoid 2 agonists
US-11655243-B2 · May 23, 2023 · US
Octahydropyrido[1,2-alpha]pyrazines as MAGL inhibitors
US-11608347-B2 · Mar 21, 2023 · US
Recent patents
Latest publications not already listed above.
Heterocyclic compounds
US-11420961-B2 · Aug 23, 2022 · US
Piperazine derivatives as MAGL inhibitors
US-11390610-B2 · Jul 19, 2022 · US
Phenyl derivatives as cannabinoid receptor 2 agonists
US-11339120-B2 · May 24, 2022 · US
Heterocyclic compounds
US-2022098176-A1 · Mar 31, 2022 · US
Pyridine derivatives
US-2022064178-A1 · Mar 3, 2022 · US
Heterocyclic compounds
US-2021387999-A1 · Dec 16, 2021 · US
Pyridine derivatives
US-11117903-B2 · Sep 14, 2021 · US
Heterocyclic compounds as monoacylglycerol lipase inhibitors
US-2021277020-A1 · Sep 9, 2021 · US
Phenyl derivatives as cannabinoid receptor 2 agonists
US-2021171441-A1 · Jun 10, 2021 · US
Novel azetidine-substituted pyridine and pyrazine compounds as inhibitors of cannabinoid receptor 2
US-2021130334-A1 · May 6, 2021 · US
Novel pyridine and pyrazine compounds as inhibitors of cannabinoid receptor 2
US-2021115011-A1 · Apr 22, 2021 · US
Pyridine and pyrazine derivatives as preferential cannabinoid 2 agonists
US-2021115027-A1 · Apr 22, 2021 · US
Radiolabeled cannabinoid receptor 2 ligand
US-2021115012-A1 · Apr 22, 2021 · US
Heterocyclic compounds
US-2021107921-A1 · Apr 15, 2021 · US
Oxazine monoacylglycerol lipase (magl) inhibitors
US-2021107920-A1 · Apr 15, 2021 · US
Heterocyclic compounds
US-2021094943-A1 · Apr 1, 2021 · US
Heterocyclic compounds
US-2021094973-A1 · Apr 1, 2021 · US
Heterocyclic compounds
US-2021094971-A1 · Apr 1, 2021 · US
Heterocyclic compounds
US-2021094972-A1 · Apr 1, 2021 · US
Octahydropyrido[1,2-alpha]pyrazines as magl inhibitors
US-2021024546-A1 · Jan 28, 2021 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Hoffmann La Roche | 37 |
| Eth Zuerich | 6 |
| Eidgenoessische Technische Hochschule Zuerich | 4 |
| Eidgenossische Technische Hochschule Zurich | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P25/00 | 28 |
| A61P35/00 | 27 |
| A61P29/00 | 24 |
| A61P1/00 | 15 |
| A61K9/4866 | 14 |